Cloning and characterization of the human BAG-1 gene promoter: upregulation by tumor-derived p53 mutants

被引:0
|
作者
Xiaolong Yang
Alan Pater
Shou-Ching Tang
机构
[1] Faculty of Medicine,Division of Basic Medical Sciences
[2] Memorial University of Newfoundland,undefined
[3] Newfoundland Cancer Treatment and Research Foundation,undefined
[4] Dr. H. Bliss Murphy Cancer Centre,undefined
来源
Oncogene | 1999年 / 18卷
关键词
BAG-1; promoter; mutant p53; transactivation;
D O I
暂无
中图分类号
学科分类号
摘要
BAG-1 is an anti-apoptotic protein that interacts with Bcl-2, Bcl-XL, Hsp70/Hsc70, Raf-1 and numerous hormone or growth factor receptors. Recently, BAG-1 has been found to be overexpressed in a variety of human cancer cell lines and some tumors. However, the molecular mechanism of BAG-1 upregulation is still unclear. In this study, we cloned 0.9 kb of human genomic DNA, BGEV, 5′ flanking the BAG-1 open reading frame. BGEV subcloned into a promoterless luciferase reporter vector conferred high promoter activity in various human cancer cell lines. Deletion analysis of this sequence localized the region of maximal BAG-1 promoter activity from nucleotide positions −353 to −54, upstream of the first start codon CTG. Sequence analysis of the BAG-1 promoter region showed the absence of a TATA box but identified a CCAAT box, several GC boxes, a CpG island and several transcriptional factor binding sites, which may be important in the regulation of BAG-1 transcription. Most importantly, functional characterization of the BAG-1 promoter in vivo demonstrated that gain-of-function p53 mutants derived from human tumors upregulated the transcription of BAG-1 RNA and the expression of a reporter gene from the BAG-1 promoter. These results indicated that we have isolated the functional constitutive BAG-1 promoter. Furthermore, the data suggested that overexpression of BAG-1 in some tumors may be due to upregulation of the human BAG-1 promoter by mutant p53.
引用
收藏
页码:4546 / 4553
页数:7
相关论文
共 50 条
  • [31] Engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants
    Waterman, MJF
    Waterman, JLF
    Halazonetis, TD
    CANCER RESEARCH, 1996, 56 (01) : 158 - 163
  • [32] CpG methylation inactivates the transcriptional activity of the promoter of the human p53 tumor suppressor gene
    Schroeder, M
    Mass, MJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (02) : 403 - 406
  • [33] INDUCTION OF APOPTOSIS BY WILD-TYPE P53 IN A HUMAN COLON TUMOR-DERIVED CELL-LINE
    SHAW, P
    BOVEY, R
    TARDY, S
    SAHLI, R
    SORDAT, B
    COSTA, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (10) : 4495 - 4499
  • [34] Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines
    Cesar Patino-Morales, Carlos
    Soto-Reyes, Ernesto
    Arechaga-Ocampo, Elena
    Ortiz-Sanchez, Elizabeth
    Antonio-Vejar, Veronica
    Pedraza-Chaverri, Jose
    Garcia-Carranca, Alejandro
    REDOX BIOLOGY, 2020, 28
  • [35] The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
    Vaughan, Catherine A.
    Singh, Shilpa
    Subler, Mark A.
    Windle, Jolene J.
    Inoue, Kazushi
    Fry, Elizabeth A.
    Pillappa, Raghavendra
    Grossman, Steven R.
    Windle, Brad
    Yeudall, W. Andrew
    Deb, Swati Palit
    Deb, Sumitra
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [36] PCR-DETECTION OF TUMOR-DERIVED P53 DNA IN CEREBROSPINAL-FLUID
    RHODES, CH
    HONSINGER, C
    SORENSON, GD
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1995, 103 (04) : 404 - 408
  • [37] Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites
    Golubovskaya, V
    Kaur, A
    Cance, W
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2004, 1678 (2-3): : 111 - 125
  • [38] CLONING OF THE SYRIAN-HAMSTER P53 GENE - STRUCTURAL AND FUNCTIONAL-CHARACTERIZATION OF THE UPSTREAM PROMOTER REGION
    ALBOR, A
    LABORDA, J
    NOTARIO, V
    MOLECULAR CARCINOGENESIS, 1994, 11 (03) : 176 - 183
  • [39] The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3
    Catherine A. Vaughan
    Shilpa Singh
    Mark A. Subler
    Jolene J. Windle
    Kazushi Inoue
    Elizabeth A. Fry
    Raghavendra Pillappa
    Steven R. Grossman
    Brad Windle
    W. Andrew Yeudall
    Swati Palit Deb
    Sumitra Deb
    Nature Communications, 12
  • [40] INVITRO EXPRESSION OF HUMAN P53 CDNA CLONES AND CHARACTERIZATION OF THE CLONED HUMAN P53 GENE
    WOLF, D
    LAVERRUDICH, Z
    ROTTER, V
    MOLECULAR AND CELLULAR BIOLOGY, 1985, 5 (08) : 1887 - 1893